Tenet Healthcare Beats Earnings Est - Analyst Blog


Tenet Healthcare Corp. ( THC ) reported first-quarter 2013 income from continuing operations of $34 million or 33 cents per share, surpassing the Zacks Consensus Estimate of 28 cents per share. Operating earnings improved from $13 million or 15 cents in the year-ago quarter.

Growth in revenues, largely driven by improved pricing, fueled the year-over-year improvement along with cost control measures.

Net loss, including $75 million from an industry-wide Medicare inpatient prospective payment settlement and a loss from discontinued operations of $2 million or 2 cents a share, along with impairments, restructuring charges, acquisition-related costs and the loss on early extinguishment of debt, was $88 million or 85 cents per share in the reported quarter.

Results compared unfavorably with $58 million or 53 cents earned in the year-ago quarter. Net income for the first quarter of 2012 included $1 million or 1 cent per share related to income from discontinued operations.

Operational Update

Net operating revenues stood at $2.39 billion, up 3.7% from $2.30 billion in the prior-year quarter. However, reported revenues lagged the Zacks Consensus Estimate of $2.62 billion.

During the reported quarter, Tenet Healthcare's net patient revenues per adjusted admission increased 1.6% on a year-over-year basis to $11,884, primarily due to improved terms of commercial managed care contracts and increased Medicare reimbursement rates.

Total admissions declined 4% from the year-ago quarter level, while adjusted admissions declined 2.5% year over year due to lower inpatient admissions, which offset higher outpatient visits. Surgeries increased 8.8%, while emergency department visits improved 3.1%.

Bad debt expense, as a percentage of revenues, increased 40 basis points year over year to 8.0%.

Tenet Healthcare posted adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) of $274 million in the reported quarter, up 16.6% from $235 million in the prior-year quarter. Adjusted EBITDA margin was 11.5%, declining 200 basis points year over year. 

Financial Position

Tenet Healthcare exited the reported quarter with cash and cash equivalents of $95 million, sinking from $364 million as of Dec 31, 2012. As of Mar 31, 2013, total assets of Tenet Healthcare were $8.9 billion and shareholder equity was $969 million.

Net cash outflow from operating activities in the reported quarter was $32 million, contracting from $42 million outflow in the year-ago quarter.

Tenet Healthcare's capital expenditures decreased to $133 million in the quarter from $136 million in the prior-year quarter.

Share Buyback

Tenet Healthcare spent $100 million to repurchase 2.5 million shares under its $500 million share buyback program during the reported quarter.


Tenet Healthcare announced its adjusted EBITDA guidance of $325 million to $375 million for the second quarter of 2013. The guidance includes $54 million associated with the expected approval of the managed care portion of the 30-month California Provider Fee program along with $31 million from the recognition of Health Information Technology (HIT) incentives.

Adjusted EBITDA guidance for 2013 was affirmed at $1.325-$1.425 billion. Operating income is projected at about $821-$951 million.

Additionally, shares outstanding as of Dec 31, 2013 are expected to be approximately 104 million. Consequently, adjusted earnings per share for 2013 are expected to be about $2.31-$3.31 for 2013.

Further, net income of Tenet Healthcare in 2013 is anticipated at around $114-$224 million. Net operating revenue is expected to be around $9.8-$10.1 billion.

Zacks Rank

Tenet Healthcare carries a Zacks Rank #4 (Sell). Other companies in the medical sector worth considering are VCA Antech Inc. ( WOOF ) - Zacks Rank #1 (Strong Buy), Centene Corp. ( CNC ) - Zacks Rank #2 (Buy) and Coventry Health Care Inc. ( CVH ) - Zacks Rank #2 (Buy).

CENTENE CORP (CNC): Free Stock Analysis Report

COVENTRY HLTHCR (CVH): Free Stock Analysis Report

TENET HEALTH (THC): Free Stock Analysis Report

VCA ANTECH INC (WOOF): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

This article appears in: Investing , Business , Earnings , Stocks

Referenced Stocks: CNC , CVH , THC , WOOF



More from Zacks.com:

Related Videos



Most Active by Volume

  • $15.85 ▲ 2.06%
  • $112.34 ▲ 4.29%
  • $57.29 ▲ 0.28%
  • $24.57 ▲ 2.89%
  • $9.32 ▲ 1.08%
  • $103.90 ▲ 2.82%
  • $105.44 ▼ 0.33%
  • $43.36 ▲ 3.68%
As of 9/2/2015, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by BankRate.com